Paralytic poliomyelitis: seasoned strategies, disappearing disease

With more than 2 years having elapsed since the last case of paralytic poliomyelitis occurred in the Western Hemisphere, significant progress has been made towards the global eradication of wild polioviruses. Poliomyelitis is disappearing from Europe, North Africa, Southern Africa, the Middle East, China, and the Pacific. Reported poliomyelitis cases declined to 15,587 cases in 1992. Current eradication strategies recommended by the World Health Organization include national mass campaigns administering oral poliovaccine to all children under 5 years of age, enhanced surveillance to detect cases of acute flaccid paralysis, creating a network of laboratories for viral diagnosis, and targeted immunisation to areas and populations where poliovirus transmission is likely to persist. The major obstacles to eradication include inadequate political support for eradication and insufficient funding, especially for the purchase of vaccine. With additional support for the international eradication effort, epidemics of poliomyelitis will cease in developing countries, and industrialised countries will be able to save the large sums spent each year on poliovaccine and rehabilitation.

[1]  J. Risi The Control of Poliomyelitis in Brazil , 1984 .

[2]  K. Chopra,et al.  Antibody response of infants in tropics to five doses of oral polio vaccine. , 1989, Journal of tropical pediatrics.

[3]  S. Sattar Virus Survival in Receiving Waters , 1981 .

[4]  J. Cuthie,et al.  Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines. , 1988, American journal of epidemiology.

[5]  M. Pallansch,et al.  Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children , 1991, The Lancet.

[6]  J. Gear Nonpolio causes of polio-like paralytic syndromes. , 1984, Reviews of infectious diseases.

[7]  J. Fox Modes of action of poliovirus vaccines and relation to resulting immunity. , 1984, Reviews of infectious diseases.

[8]  J. Andrus,et al.  Eradication of poliomyelitis: progress in the Americas. , 1991, The Pediatric infectious disease journal.

[9]  T. John Antibody response of infants in tropics to five doses of oral polio vaccine. , 1976, British medical journal.

[10]  C. D. de Quadros,et al.  Poliomyelitis case confirmation: characteristics for use by national eradication programmes. , 1992, Bulletin of the World Health Organization.

[11]  M. Pallansch,et al.  Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  W. Orenstein,et al.  RANDOMISED TRIAL OF ALTERNATIVE FORMULATIONS OF ORAL POLIOVACCINE IN BRAZIL , 1988, The Lancet.

[13]  Melnick Jl Poliomyelitis: eradication in sight. , 1992 .

[14]  M. Deming,et al.  Epidemic poliomyelitis in The Gambia following the control of poliomyelitis as an endemic disease. II. Clinical efficacy of trivalent oral polio vaccine. , 1992, American journal of epidemiology.

[15]  J. Modlin Mucosal immunity following oral poliovirus vaccine and enhanced potency inactivated poliovirus vaccine immunization , 1991, The Pediatric infectious disease journal.

[16]  J. Melnick Enterovirus type 71 infections: a varied clinical pattern sometimes mimicking paralytic poliomyelitis. , 1984, Reviews of infectious diseases.

[17]  T. Tulchinsky,et al.  A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas. , 1989, American journal of public health.

[18]  J. Castillo Pathogens of Siphonaptera (fleas). , 1980, Bulletin of the World Health Organization.

[19]  I. Onorato,et al.  Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines. , 1991, The Journal of infectious diseases.

[20]  A R Hinman,et al.  Field evaluation of vaccine efficacy. , 1985, Bulletin of the World Health Organization.

[21]  W. Foege,et al.  Progress in polio eradication , 1993, The Lancet.

[22]  R. R. Cruz Cuba: Mass Polio Vaccination Program, 1962–1982 , 1984 .

[23]  S. Plotkin Current issues in evaluating the efficacy of oral poliovirus vaccine and inactivated poliovirus vaccine immunization , 1991, The Pediatric infectious disease journal.

[24]  A. Sabin,et al.  Live, orally given poliovirus vaccine. Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses. , 1960 .

[25]  P. Wright,et al.  Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. , 1991, Reviews of infectious diseases.

[26]  H. Hull,et al.  Screening of cases of acute flaccid paralysis for poliomyelitis eradication: ways to improve specificity. , 1992, Bulletin of the World Health Organization.